Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficiency of Pulsed Field Ablation and Radiofrequency Ablation in the Treatment of Paroxysmal Supraventricular Tachycardia：a Retrospective and Propensity Score Matching Study

NCT06573853 is registered in ClinicalTrials.gov with Caijie Shen as lead sponsor.

NCT NCT06573853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06573853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficiency of Pulsed Field Ablation and Radiofrequency Ablation in the Treatment of Paroxysmal Supraventricular Tachycardia：a Retrospective and Propensity Score Matching Study
Lead sponsor
Caijie Shen
Phase
Observational
Overall status
Recruiting
Start date
October 11, 2022
Completion date
June 30, 2025
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catheter ablation, paroxysmal supraventricular tachycardia